Motoki Fujita
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Motoki Fujita has a total of 147 co-authors. Here are the top co-authors by number of shared publications:
Ryosuke Tsuruta
Advanced Medical Emergency and Critical Care Center, Yamaguchi University Hospital, Ube, Japan
22 shared publicationsMasaki Todani
Advanced Medical Emergency and Critical Care Center, Yamaguchi University Hospital, Ube, Japan
12 shared publicationsYasutaka Oda
Advanced Medical Emergency and Critical Care Center, Yamaguchi University Hospital, Ube, Japan
11 shared publicationsKotaro Kaneda
10 shared publications- Shoji Yokobori
Department of Advanced Emergency and Critical Care Center, Nippon Medical School Hospital, Tokyo 113-8603, Japan
7 shared publications Shunji Kasaoka
Advanced Medical Emergency and Critical Care Center Yamaguchi University Hospital, Japan
7 shared publications
Latest Publications
- Open Access
- 25 July 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Intravenous hydrogen-rich acetated Ringer’s solution attenuates liver injury in heatstroke rats through endothelial glycocalyx preservation
Heatstroke is a life-threatening systemic disorder characterized by hyperthermia, inflammatory activation, endothelial injury, and multiple organ dysfunction. The liver is particularly vulnerable, but effective post-onset therapeutic strategies remain limited. This study examined whether intravenous hydrogen-rich acetated Ringer’s solution (H-AR) attenuates liver injury after heatstroke onset in rats, in comparison with acetated Ringer’s solution alone (Control) and 2% hydrogen inhalation (HI). Liver injury was assessed 60 min after onset using histological scoring and liver enzyme measurements. Circulating markers of inflammation and endothelial injury, endothelial glycocalyx ultrastructure, and 24-h survival were also evaluated. Thermal exposure was comparable among the heatstroke groups. Both H-AR and HI significantly reduced histological liver injury scores compared with Control; H-AR showed significantly greater attenuation than HI and was the only intervention that significantly reduced alanine aminotransferase levels. Both hydrogen-based interventions suppressed high-mobility group box 1 and syndecan-1, preserved endothelial glycocalyx structure, and improved 24-h survival compared with Control. These findings suggest that post-onset intravenous H-AR attenuates heatstroke-associated liver injury, potentially through reduced inflammatory activation and endothelial glycocalyx preservation, and may offer advantages over hydrogen inhalation with respect to hepatoprotection.
- 25 July 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessIntravenous hydrogen-rich acetated Ringer’s solution attenuates liver injury in heatstroke rats through endothelial glycocalyx preservation
Heatstroke is a life-threatening systemic disorder characterized by hyperthermia, inflammatory activation, endothelial injury, and multiple organ dysfunction. The liver is particularly vulnerable, but effective post-onset therapeutic strategies remain limited. This study examined whether intravenous hydrogen-rich acetated Ringer’s solution (H-AR) attenuates liver injury after heatstroke onset in rats, in comparison with acetated Ringer’s solution alone (Control) and 2% hydrogen inhalation (HI). Liver injury was assessed 60 min after onset using histological scoring and liver enzyme measurements. Circulating markers of inflammation and endothelial injury, endothelial glycocalyx ultrastructure, and 24-h survival were also evaluated. Thermal exposure was comparable among the heatstroke groups. Both H-AR and HI significantly reduced histological liver injury scores compared with Control; H-AR showed significantly greater attenuation than HI and was the only intervention that significantly reduced alanine aminotransferase levels. Both hydrogen-based interventions suppressed high-mobility group box 1 and syndecan-1, preserved endothelial glycocalyx structure, and improved 24-h survival compared with Control. These findings suggest that post-onset intravenous H-AR attenuates heatstroke-associated liver injury, potentially through reduced inflammatory activation and endothelial glycocalyx preservation, and may offer advantages over hydrogen inhalation with respect to hepatoprotection.
- Open Access
- 24 April 2026
- Published by Elsevier in Resuscitation Plus
- Vol. 29
Increased abdominal fat accumulation is associated with decreased survival to hospital admission in out-of-hospital cardiac arrest: a single center retrospective study
- 24 April 2026
- Published by Elsevier in Resuscitation Plus
- Vol. 29
Open AccessIncreased abdominal fat accumulation is associated with decreased survival to hospital admission in out-of-hospital cardiac arrest: a single center retrospective study
- Open Access
- 28 January 2026
- Published by Wiley in Acute Medicine & Surgery
- Vol. 13 (1)
Evaluating the Efficacy of Hyperbaric Oxygen Therapy for Acute Carbon Monoxide Poisoning: A Systematic Review and Meta‐Analysis
Aim: To reassess the efficacy of hyperbaric oxygen (HBO) therapy for acute carbon monoxide (CO) poisoning through a systematic review and meta‐analysis, including a subgroup analysis of treatment pressures exceeding 2.5 atm absolute (ATA). Methods: We conducted a systematic review and meta‐analysis of randomized controlled trials (RCTs) evaluating HBO therapy for acute CO poisoning. A literature search was performed in MEDLINE, CENTRAL, and Ichushi‐Web databases, focusing on RCTs published up to June 2024. Only adult patients (≥ 18 years) were included, and studies were screened following PRISMA guidelines. Data extraction and quality assessment were conducted by two independent reviewers using the Cochrane risk of bias tool and the GRADE approach. Statistical analysis used a random effects model, with outcomes expressed as odds ratios (OR) and 95% confidence intervals (CI). Results: Six studies were included, and no significant benefit of HBO therapy was observed in terms of reducing mortality or improving neurological outcomes. The subgroup analysis of HBO at ≥ 2.5 ATA also showed no significant advantage over control treatments. Moderate to significant heterogeneity was found across included studies, and the quality of evidence was rated as low to very low. Conclusions: The efficacy of HBO therapy, even at ≥ 2.5 ATA, for improving outcomes in acute CO poisoning remains unproven. Despite these findings, HBO therapy may still hold potential benefits that require further exploration. High‐quality, multicenter RCTs are necessary to better define its role in the treatment of CO poisoning. Trial Registration: UMIN Clinical Trials Registry: UMIN000054641
- 28 January 2026
- Published by Wiley in Acute Medicine & Surgery
- Vol. 13 (1)
Open AccessEvaluating the Efficacy of Hyperbaric Oxygen Therapy for Acute Carbon Monoxide Poisoning: A Systematic Review and Meta‐Analysis
Aim: To reassess the efficacy of hyperbaric oxygen (HBO) therapy for acute carbon monoxide (CO) poisoning through a systematic review and meta‐analysis, including a subgroup analysis of treatment pressures exceeding 2.5 atm absolute (ATA). Methods: We conducted a systematic review and meta‐analysis of randomized controlled trials (RCTs) evaluating HBO therapy for acute CO poisoning. A literature search was performed in MEDLINE, CENTRAL, and Ichushi‐Web databases, focusing on RCTs published up to June 2024. Only adult patients (≥ 18 years) were included, and studies were screened following PRISMA guidelines. Data extraction and quality assessment were conducted by two independent reviewers using the Cochrane risk of bias tool and the GRADE approach. Statistical analysis used a random effects model, with outcomes expressed as odds ratios (OR) and 95% confidence intervals (CI). Results: Six studies were included, and no significant benefit of HBO therapy was observed in terms of reducing mortality or improving neurological outcomes. The subgroup analysis of HBO at ≥ 2.5 ATA also showed no significant advantage over control treatments. Moderate to significant heterogeneity was found across included studies, and the quality of evidence was rated as low to very low. Conclusions: The efficacy of HBO therapy, even at ≥ 2.5 ATA, for improving outcomes in acute CO poisoning remains unproven. Despite these findings, HBO therapy may still hold potential benefits that require further exploration. High‐quality, multicenter RCTs are necessary to better define its role in the treatment of CO poisoning. Trial Registration: UMIN Clinical Trials Registry: UMIN000054641
- Open Access
- 1 January 2026
- Published by Wiley in Acute Medicine & Surgery
- Vol. 13 (1) , e70151
Clinical Course of Pediatric Versus Adult Mamushi ( Gloydius blomhoffii ) Envenomation: A Secondary Analysis of the OROCHI Study
Aim: Mamushi ( Gloydius blomhoffii ) bite is the most common type of snakebite in Japan. However, clinical information on pediatric patients remains limited. This study aimed to clarify the clinical characteristics of pediatric cases of mamushi envenomation by making comparisons with adult cases. Methods: This secondary analysis used data from the OROCHI study, a multicenter prospective observational study conducted at 24 hospitals in Japan, of patients hospitalized for confirmed or suspected mamushi envenomation. The primary outcome was hospital stay. Secondary outcomes included adverse events, pain scores, and the grade of swelling. Patients were classified into pediatric (< 18 years) and adult (≥ 18 years) groups. Results: Of the 106 patients enrolled in the OROCHI study, 99 met the inclusion criteria for this analysis (7 pediatric cases; 92 adult cases). There was no significant difference in median (interquartile range) hospital stay between the pediatric and adult groups (4 days; p = 0.375). Among patients who received antivenom, no adverse reactions were observed in the pediatric group, whereas four adults experienced adverse reactions, including one case of anaphylaxis. The pain scores at antivenom administration were higher in pediatric patients (median 10 vs. 5), but no significant differences were observed after 6 h. The grade of swelling did not differ significantly between the groups at any time point. Conclusion: The clinical course and outcomes of pediatric patients with mamushi envenomation appear similar to those of adult patients. Further accumulation of pediatric cases is warranted to strengthen these findings.
- 1 January 2026
- Published by Wiley in Acute Medicine & Surgery
- Vol. 13 (1) , e70151
Open AccessClinical Course of Pediatric Versus Adult Mamushi ( Gloydius blomhoffii ) Envenomation: A Secondary Analysis of the OROCHI Study
Aim: Mamushi ( Gloydius blomhoffii ) bite is the most common type of snakebite in Japan. However, clinical information on pediatric patients remains limited. This study aimed to clarify the clinical characteristics of pediatric cases of mamushi envenomation by making comparisons with adult cases. Methods: This secondary analysis used data from the OROCHI study, a multicenter prospective observational study conducted at 24 hospitals in Japan, of patients hospitalized for confirmed or suspected mamushi envenomation. The primary outcome was hospital stay. Secondary outcomes included adverse events, pain scores, and the grade of swelling. Patients were classified into pediatric (< 18 years) and adult (≥ 18 years) groups. Results: Of the 106 patients enrolled in the OROCHI study, 99 met the inclusion criteria for this analysis (7 pediatric cases; 92 adult cases). There was no significant difference in median (interquartile range) hospital stay between the pediatric and adult groups (4 days; p = 0.375). Among patients who received antivenom, no adverse reactions were observed in the pediatric group, whereas four adults experienced adverse reactions, including one case of anaphylaxis. The pain scores at antivenom administration were higher in pediatric patients (median 10 vs. 5), but no significant differences were observed after 6 h. The grade of swelling did not differ significantly between the groups at any time point. Conclusion: The clinical course and outcomes of pediatric patients with mamushi envenomation appear similar to those of adult patients. Further accumulation of pediatric cases is warranted to strengthen these findings.
- Open Access
- 1 January 2026
- Published by Wiley in Acute Medicine & Surgery
- Vol. 13 (1) , e70147
Response to Comments on “Evaluating the Efficacy of Hyperbaric Oxygen Therapy for Acute Carbon Monoxide Poisoning”
- 1 January 2026
- Published by Wiley in Acute Medicine & Surgery
- Vol. 13 (1) , e70147
Open AccessResponse to Comments on “Evaluating the Efficacy of Hyperbaric Oxygen Therapy for Acute Carbon Monoxide Poisoning”
- Open Access
- 3 April 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-9
Increased fat accumulation may be associated with severe muscle wasting in critically ill patients: a prospective observational study
Obesity has been hypothesized to attenuate muscle wasting in critically ill patients due to increased ketogenesis. This study examined the associations between fat mass volume, ketone bodies, and muscle wasting in critically ill patients. We conducted a prospective study in an emergency intensive care unit (ICU) from November 2021 to October 2023, enrolling adult patients with an expected ICU stay of ≥ 7 days and abdominal computed tomography (CT) performed within 24 h of admission. Patients were classified as adipose or lean based on fat area measured via CT. The primary outcome was severe muscle wasting, defined as a > 10% decrease in the rectus femoris cross-sectional area measured by ultrasonography from day 1 to day 7. Among 134 enrolled patients, 108 were evaluable (57% male, median age 73 years). Severe muscle wasting was more frequent in the adipose group (48%) than in the lean group (27%, p = 0.023). Multivariate analysis confirmed a higher risk of muscle wasting in the adipose group (adjusted OR 2.52, p = 0.034). BHB levels were inversely correlated with fat area and associated with a reduced risk of muscle wasting. Contrary to our hypothesis, obesity increased the risk of muscle wasting, potentially due to decreased ketogenesis. 200/200 words
- 3 April 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-9
Open AccessIncreased fat accumulation may be associated with severe muscle wasting in critically ill patients: a prospective observational study
Obesity has been hypothesized to attenuate muscle wasting in critically ill patients due to increased ketogenesis. This study examined the associations between fat mass volume, ketone bodies, and muscle wasting in critically ill patients. We conducted a prospective study in an emergency intensive care unit (ICU) from November 2021 to October 2023, enrolling adult patients with an expected ICU stay of ≥ 7 days and abdominal computed tomography (CT) performed within 24 h of admission. Patients were classified as adipose or lean based on fat area measured via CT. The primary outcome was severe muscle wasting, defined as a > 10% decrease in the rectus femoris cross-sectional area measured by ultrasonography from day 1 to day 7. Among 134 enrolled patients, 108 were evaluable (57% male, median age 73 years). Severe muscle wasting was more frequent in the adipose group (48%) than in the lean group (27%, p = 0.023). Multivariate analysis confirmed a higher risk of muscle wasting in the adipose group (adjusted OR 2.52, p = 0.034). BHB levels were inversely correlated with fat area and associated with a reduced risk of muscle wasting. Contrary to our hypothesis, obesity increased the risk of muscle wasting, potentially due to decreased ketogenesis. 200/200 words
- Open Access
- 8 May 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (5) , e0285525
Temperature difference between jugular bulb and pulmonary artery is associated with neurological outcome in patients with severe traumatic brain injury: A post hoc analysis of a brain hypothermia study
Background: The purpose of this study was to examine whether the temperature difference between the jugular bulb and pulmonary artery (ΔTjb-pa) is associated with the neurological outcome of patients with severe traumatic brain injury (TBI). Methods: We conducted a post hoc analysis of a multicenter randomized controlled trial of mild therapeutic hypothermia (TH, 32.0–34.0°C) or fever control (FC, 35.5–37.0°C) for the patients with severe TBI. ΔTjb-pa averaged every 12 h and the variation in ΔTjb-pa were compared between patients with favorable (n = 39) and unfavorable (n = 37) neurological outcomes. These values were also compared in the TH and FC subgroups. Results: The average ΔTjb-pa values in patients with favorable and unfavorable outcomes were 0.24 ± 0.23 and 0.06 ± 0.36°C, respectively (P < 0.001). ΔTjb-pa trended significantly higher in the favorable outcome patients than in the unfavorable outcome patients throughout the 120 h after onset of severe TBI (P < 0.001). The variation in ΔTjb-pa from 0 to 72 h was significantly lower in the favorable outcome patients than in the unfavorable outcome patients (0.8 ± 0.8 vs 1.8 ± 2.5°C, respectively, P = 0.013). From 72 to 120 h, there was no significant difference in the variation in ΔTjb-pa. Significant differences between patients with favorable and unfavorable outcomes in ΔTjb-pa and the variation in ΔTjb-pa were similar in the TH subgroup, but not evident in the FC subgroup. Conclusions: A reduction in ΔTjb-pa and greater variation in ΔTjb-pa were associated with an unfavorable outcome in patients with severe TBI, especially those treated with TH. When treating severe TBI patients, it is important to understand that there will be differences in temperature reflecting the brain environment and the systemic temperature, depending on the severity and outcome of TBI during TH.
- 8 May 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (5) , e0285525
Open AccessTemperature difference between jugular bulb and pulmonary artery is associated with neurological outcome in patients with severe traumatic brain injury: A post hoc analysis of a brain hypothermia study
Background: The purpose of this study was to examine whether the temperature difference between the jugular bulb and pulmonary artery (ΔTjb-pa) is associated with the neurological outcome of patients with severe traumatic brain injury (TBI). Methods: We conducted a post hoc analysis of a multicenter randomized controlled trial of mild therapeutic hypothermia (TH, 32.0–34.0°C) or fever control (FC, 35.5–37.0°C) for the patients with severe TBI. ΔTjb-pa averaged every 12 h and the variation in ΔTjb-pa were compared between patients with favorable (n = 39) and unfavorable (n = 37) neurological outcomes. These values were also compared in the TH and FC subgroups. Results: The average ΔTjb-pa values in patients with favorable and unfavorable outcomes were 0.24 ± 0.23 and 0.06 ± 0.36°C, respectively (P < 0.001). ΔTjb-pa trended significantly higher in the favorable outcome patients than in the unfavorable outcome patients throughout the 120 h after onset of severe TBI (P < 0.001). The variation in ΔTjb-pa from 0 to 72 h was significantly lower in the favorable outcome patients than in the unfavorable outcome patients (0.8 ± 0.8 vs 1.8 ± 2.5°C, respectively, P = 0.013). From 72 to 120 h, there was no significant difference in the variation in ΔTjb-pa. Significant differences between patients with favorable and unfavorable outcomes in ΔTjb-pa and the variation in ΔTjb-pa were similar in the TH subgroup, but not evident in the FC subgroup. Conclusions: A reduction in ΔTjb-pa and greater variation in ΔTjb-pa were associated with an unfavorable outcome in patients with severe TBI, especially those treated with TH. When treating severe TBI patients, it is important to understand that there will be differences in temperature reflecting the brain environment and the systemic temperature, depending on the severity and outcome of TBI during TH.
- Open Access
- 1 January 2023
- Published by Japanese Society of Toxicology in The Journal of Toxicological Sciences
- Vol. 48 (12) , 641-644
A case of pulmonary edema due to guanfacine intoxication with measurement of serum guanfacine concentrations
Guanfacine hydrochloride extended-release (GXR) is used to treat attention deficit hyperactivity disorder. It is a selective α2A-adrenorecepor agonist that was reported to cause QT prolongation and hypotension in the event of overdosing. We report the case of a 17-year-old man who took 226 tablets of GXR 3 mg for attempted suicide. He was found complaining of dyspnea, and emergency medical services were called. When the patient was transferred to our hospital, his Glasgow coma scale was 12 (E4V3M5). He was agitated and hypoxemic. He was intubated for invasive mechanical ventilation under sedation. His chest X-ray and computed tomography scan showed pulmonary edema. Transthoracic echocardiography showed markedly reduced cardiac function. His serum guanfacine concentration peaked on day 3 after admission. His pulmonary edema improved quickly after a decrease in serum guanfacine concentration, but cardiac decompensation persisted for about 1 month. This case reveals that the decline in cardiac function after guanfacine intoxication is prolonged even after its serum concentration has decreased.
- 1 January 2023
- Published by Japanese Society of Toxicology in The Journal of Toxicological Sciences
- Vol. 48 (12) , 641-644
Open AccessA case of pulmonary edema due to guanfacine intoxication with measurement of serum guanfacine concentrations
Guanfacine hydrochloride extended-release (GXR) is used to treat attention deficit hyperactivity disorder. It is a selective α2A-adrenorecepor agonist that was reported to cause QT prolongation and hypotension in the event of overdosing. We report the case of a 17-year-old man who took 226 tablets of GXR 3 mg for attempted suicide. He was found complaining of dyspnea, and emergency medical services were called. When the patient was transferred to our hospital, his Glasgow coma scale was 12 (E4V3M5). He was agitated and hypoxemic. He was intubated for invasive mechanical ventilation under sedation. His chest X-ray and computed tomography scan showed pulmonary edema. Transthoracic echocardiography showed markedly reduced cardiac function. His serum guanfacine concentration peaked on day 3 after admission. His pulmonary edema improved quickly after a decrease in serum guanfacine concentration, but cardiac decompensation persisted for about 1 month. This case reveals that the decline in cardiac function after guanfacine intoxication is prolonged even after its serum concentration has decreased.
- Open Access
- 1 January 2023
- Published by Wiley in Acute Medicine & Surgery
- Vol. 10 (1) , e897
Rapid rewarming rate associated with favorable neurological outcomes in patients with post–cardiac arrest syndrome patients treated with targeted temperature management
Aim: To determine whether the rewarming rate is associated with neurological outcomes in patients with post–cardiac arrest syndrome treated with targeted temperature management (TTM) at 34°C.Methods: We conducted a retrospective analysis of a nationwide cohort study of out‐of‐hospital cardiac arrest in Japan. Adult patients who experienced a return of spontaneous circulation and completed TTM at 34°C between June 2014 and December 2019 were divided equally into three groups (slow, moderate, and rapid) according to their rewarming rates from 34°C to 36°C. The rates of favorable neurological outcomes (Cerebral Performance Category of 1–2 after 30 days) were compared among the groups, and the adjusted odds ratios for a favorable neurological outcome were calculated for the groups.Results: We analyzed 348, 357, and 358 patients in the slow, moderate, and rapid groups, respectively. The periods of rewarming from 34°C to 36°C were 41.9 ± 10.5, 22.4 ± 1.8, and 12.2 ± 3.6 h, respectively. The number of favorable neurological outcomes after 30 days was 121 (34.8%), 125 (35.0%), and 147 (41.1%), respectively, with no significant differences among the three groups (p = 0.145). Rapid rewarming was independently associated with a favorable neurological outcome compared with slow rewarming (adjusted odds ratio 1.57 [95% confidence interval 1.04–2.37]; p = 0.031).Conclusions: Rapid rewarming after TTM at 34°C was associated with a more favorable neurological outcome than slow rewarming.
- 1 January 2023
- Published by Wiley in Acute Medicine & Surgery
- Vol. 10 (1) , e897
Open AccessRapid rewarming rate associated with favorable neurological outcomes in patients with post–cardiac arrest syndrome patients treated with targeted temperature management
Aim: To determine whether the rewarming rate is associated with neurological outcomes in patients with post–cardiac arrest syndrome treated with targeted temperature management (TTM) at 34°C.Methods: We conducted a retrospective analysis of a nationwide cohort study of out‐of‐hospital cardiac arrest in Japan. Adult patients who experienced a return of spontaneous circulation and completed TTM at 34°C between June 2014 and December 2019 were divided equally into three groups (slow, moderate, and rapid) according to their rewarming rates from 34°C to 36°C. The rates of favorable neurological outcomes (Cerebral Performance Category of 1–2 after 30 days) were compared among the groups, and the adjusted odds ratios for a favorable neurological outcome were calculated for the groups.Results: We analyzed 348, 357, and 358 patients in the slow, moderate, and rapid groups, respectively. The periods of rewarming from 34°C to 36°C were 41.9 ± 10.5, 22.4 ± 1.8, and 12.2 ± 3.6 h, respectively. The number of favorable neurological outcomes after 30 days was 121 (34.8%), 125 (35.0%), and 147 (41.1%), respectively, with no significant differences among the three groups (p = 0.145). Rapid rewarming was independently associated with a favorable neurological outcome compared with slow rewarming (adjusted odds ratio 1.57 [95% confidence interval 1.04–2.37]; p = 0.031).Conclusions: Rapid rewarming after TTM at 34°C was associated with a more favorable neurological outcome than slow rewarming.
- Open Access
- 1 January 2023
- Published by Wiley in Acute Medicine & Surgery
- Vol. 10 (1) , e892
Effects of cardiopulmonary resuscitation instructions on the outcomes of out‐of‐hospital cardiac arrest: An analysis of the JAAM‐OHCA registry
Aim: To determine whether dispatcher‐provided cardiopulmonary resuscitation (CPR) instructions improve the outcomes of out‐of‐hospital cardiac arrest (OHCA).Methods: Cases registered in the Japanese Association for Acute Medicine Out‐of‐Hospital Cardiac Arrest (JAAM‐OHCA) Registry between June 2014 and December 2019 were included. Cases in which the dispatcher provided CPR instructions to the bystander were included in the “Instructions” group”, and cases without CPR instructions were included in the “No Instructions” group. The primary outcome was the proportion of patients with a favorable neurological outcome, defined as a Glasgow–Pittsburgh cerebral performance category scale of 1 to 2 at 1 month after OHCA.Results: Overall, 51,199 patients with OHCA were registered in the JAAM‐OHCA Registry during the study period. Of these, 33,745 were eligible for the study, with 16,509 in the Instructions group and 17,236 in the No Instructions group. The proportion of patients with a favorable neurological outcome at 1 month after OHCA was inferior in the Instructions group than in the No Instructions group (2.3% versus 3.0%, p < 0.001). After adjustment for patient background characteristics, no association was found between CPR instructions provided by a dispatcher and favorable neurological outcomes at 1 month after OHCA (adjusted odds ratio, 1.000; 95% confidence interval, 0.869–1.151, p = 0.996).Conclusion: The present study found no clear clinical benefit of dispatcher‐provided CPR instructions on the neurological outcomes of cases with OHCA.
- 1 January 2023
- Published by Wiley in Acute Medicine & Surgery
- Vol. 10 (1) , e892
Open AccessEffects of cardiopulmonary resuscitation instructions on the outcomes of out‐of‐hospital cardiac arrest: An analysis of the JAAM‐OHCA registry
Aim: To determine whether dispatcher‐provided cardiopulmonary resuscitation (CPR) instructions improve the outcomes of out‐of‐hospital cardiac arrest (OHCA).Methods: Cases registered in the Japanese Association for Acute Medicine Out‐of‐Hospital Cardiac Arrest (JAAM‐OHCA) Registry between June 2014 and December 2019 were included. Cases in which the dispatcher provided CPR instructions to the bystander were included in the “Instructions” group”, and cases without CPR instructions were included in the “No Instructions” group. The primary outcome was the proportion of patients with a favorable neurological outcome, defined as a Glasgow–Pittsburgh cerebral performance category scale of 1 to 2 at 1 month after OHCA.Results: Overall, 51,199 patients with OHCA were registered in the JAAM‐OHCA Registry during the study period. Of these, 33,745 were eligible for the study, with 16,509 in the Instructions group and 17,236 in the No Instructions group. The proportion of patients with a favorable neurological outcome at 1 month after OHCA was inferior in the Instructions group than in the No Instructions group (2.3% versus 3.0%, p < 0.001). After adjustment for patient background characteristics, no association was found between CPR instructions provided by a dispatcher and favorable neurological outcomes at 1 month after OHCA (adjusted odds ratio, 1.000; 95% confidence interval, 0.869–1.151, p = 0.996).Conclusion: The present study found no clear clinical benefit of dispatcher‐provided CPR instructions on the neurological outcomes of cases with OHCA.